1-3 of 3
Mónica Coronado
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Randomized Trial Comparing Standard RCHOP Versus Brcap (bortezomib, rituximab, cyclophosphamide, adriamycin and prednisone) As First Line Treatment in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma (DLBCL). a Study from Spanish Group Geltamo

Eva González-Barca, MD PhD, Estrella Carrillo-Cruz, MD, Carlos Grande, MD PhD, Alejandro Martín, MD PhD, Mónica Coronado, MD, Santiago Montes-Moreno, MD, Santiago Mercadal, MD, Josep Maria Roncero, MD, Jaime Pérez de Oteyza, MD, Concepción Nicolás, MD, María José Rodríguez-Salazar, MD, Juan-Manuel Sancho, Luis Palomera, MD PhD, Javier López-Jiménez, MD, Carmen Albo, MD, Francisco-Javier Peñalver, MD, José Ángel Hernández, MD, Armando López-Guillermo, MD PhD, María José Ramírez, MD, Isidro Jarque, MD, Joan Bargay, MD, Miguel Canales, MD PhD, Eulogio Conde, MD PhD, Dolores Caballero, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4201.
https://doi.org/10.1182/blood.V128.22.4201.4201
Published: 2016
Journal Articles

Central Review of PET/TC: First Spanish Experience in a Phase 2 Randomized Trial in Diffuse Large B-Cell Lymphoma (DLBCL) Patients

Mónica Coronado-Poggio, Ana Cristina Hernandez-Martinez, M. Pilar Sarandeses, Montse Cortés-Romera, Marc Simó-Perdigó, Xavier Setoain, Amanda Rotger, Carlos Grande-Garcia, González-Barca Eva, Isabel Borrego, Pilar Tamayo, Lina García-Cañamaque, Javier Banzo, González Francisco Manuel, Rodriguez Begoña, Bello Pilar, Pablo Sopena, Fernando Ortega, Ana Allende, Jaime Daumal, Jose Manuel Nogueiras, Armando López-Guillermo, Dolores Caballero
Journal: Blood
Blood (2015) 126 (23): 5042.
https://doi.org/10.1182/blood.V126.23.5042.5042
Published: 2015
Journal Articles

Phase 2 Randomized Trial Comparing 6 Cycles of Standard RCHOP Chemotherapy Vs 6 Cycles of Brcap (bortezomib, rituximab, cyclophosphamide, adriamicine and prednisone) As First Line Treatment in Young Patients with Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Interim Analysis

Eva González-Barca, MD PhD, Estrella Carrillo, Carlos Grande, MD, Alejandro Martín, Mónica Coronado, Santiago Montes-Moreno, Jaime Perez de Oteyza, Concepción Nicolas, Juan-Manuel Sancho, Luis Palomera, MDPhD, Javier Lopez, Sr., MD PhD, Armando Lopez-Guillermo, Francisco Javier Peñalver, José Ángel Hernández, MD, Maria Jose Ramirez, Isidro Jarque, Joan Bargay, MD, Mª José Rodríguez, Miguel Canales, Carmen Albo, Maite Encuentra, Dolores Caballero
Journal: Blood
Blood (2015) 126 (23): 1514.
https://doi.org/10.1182/blood.V126.23.1514.1514
Published: 2015